Quick Answer
VSEE HEALTH, INC. reported Cash and Equivalents of $5.27 million for fiscal year 2025.
VSEE HEALTH, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $5.27M | +1514.9% |
| 2024 | $326.1K | +174.7% |
| 2023 | $118.7K | +11.0% |
| 2022 | $107.0K | -85.9% |
| 2021 | $760.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $472.8K | -79.7% | +62.1% |
| June 30, 2025 | $291.6K | -73.6% | -28.9% |
| March 31, 2025 | $410.1K | — | +25.8% |
| December 31, 2024 | $326.1K | +174.7% | -86.0% |
| September 30, 2024 | $2.33M | +458940.8% | +110.4% |
| June 30, 2024 | $1.11M | +3483.7% | +831.5% |
| December 31, 2023 | $118.7K | +11.0% | +23318.9% |
| September 30, 2023 | $507.00 | -98.9% | -98.4% |
- VSEE HEALTH, INC. showed an increase of +1514.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, VSEE HEALTH, INC.’s cash and equivalents has grown by 592.9% (from $760.0 thousand to $5.27 million).
- The most recent figure is from VSEE HEALTH, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: